Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (31-40 of 2,959) with videos related to

Pageof 296
Sort By:
Angiology|January 1, 1977
Theoretical and practical aspects of thrombolytic therapyJ Hirsh
Annals of Palliative Medicine|April 6, 2015
Denosumab will play an important role in patients with solid tumours and bone metastasesVera Hirsh
Frontiers in Oncology|July 2, 2014
Targeted treatments of bone metastases in patients with lung cancerVera Hirsh
Seminars in Hematology|December 17, 1997
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosisJ Hirsh
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 1, 2015
Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on AfatinibVera Hirsh
Australian and New Zealand Journal of Medicine|October 1, 1992
Overview of low molecular weight heparins and heparinoids: basic and clinical aspectsJ Hirsh
Current Oncology (Toronto, Ont.)|December 15, 2010
Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancerVera Hirsh
Biochimica Et Biophysica Acta|August 24, 1983
An alternative explanation for phase transitions observed in quick frozen calcium cardiolipin solutionA Hirsh
Annals of the New York Academy of Sciences|January 1, 1982
Antiplatelet agents: their role in the prevention of sudden deathJ Hirsh
Future Oncology (London, England)|July 8, 2011
Afatinib (BIBW 2992) development in non-small-cell lung cancerVera Hirsh
Pageof 296

Showing results (31-40 of 2,959) with videos related to

Sort By:
Pageof 296
Angiology|January 1, 1977
Theoretical and practical aspects of thrombolytic therapyJ Hirsh
Annals of Palliative Medicine|April 6, 2015
Denosumab will play an important role in patients with solid tumours and bone metastasesVera Hirsh
Frontiers in Oncology|July 2, 2014
Targeted treatments of bone metastases in patients with lung cancerVera Hirsh
Seminars in Hematology|December 17, 1997
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosisJ Hirsh
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 1, 2015
Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on AfatinibVera Hirsh
Australian and New Zealand Journal of Medicine|October 1, 1992
Overview of low molecular weight heparins and heparinoids: basic and clinical aspectsJ Hirsh
Current Oncology (Toronto, Ont.)|December 15, 2010
Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancerVera Hirsh
Biochimica Et Biophysica Acta|August 24, 1983
An alternative explanation for phase transitions observed in quick frozen calcium cardiolipin solutionA Hirsh
Annals of the New York Academy of Sciences|January 1, 1982
Antiplatelet agents: their role in the prevention of sudden deathJ Hirsh
Future Oncology (London, England)|July 8, 2011
Afatinib (BIBW 2992) development in non-small-cell lung cancerVera Hirsh
Pageof 296